Compare LUCY & INBS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | LUCY | INBS |
|---|---|---|
| Founded | 2017 | 2016 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Ophthalmic Goods | Medical Specialities |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 7.2M | 6.5M |
| IPO Year | 2021 | 2019 |
| Metric | LUCY | INBS |
|---|---|---|
| Price | $0.83 | $1.99 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 114.5K | 22.6K |
| Earning Date | 11-20-2026 | 11-16-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 63.39 | N/A |
| EPS | ★ N/A | N/A |
| Revenue | ★ $2,661,669.00 | $1,980,484.00 |
| Revenue This Year | $170.51 | $44.72 |
| Revenue Next Year | $205.56 | $44.26 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 62.65 | N/A |
| 52 Week Low | $0.65 | $0.54 |
| 52 Week High | $2.02 | $24.90 |
| Indicator | LUCY | INBS |
|---|---|---|
| Relative Strength Index (RSI) | 44.17 | 61.86 |
| Support Level | $0.78 | $1.52 |
| Resistance Level | $0.89 | $2.45 |
| Average True Range (ATR) | 0.06 | 0.14 |
| MACD | -0.00 | 0.04 |
| Stochastic Oscillator | 52.01 | 92.16 |
Innovative Eyewear Inc is engaged in developing and selling eyeglasses and sunglasses, which are designed to allow customers to remain connected to their digital lives, while also offering prescription eyewear and sun protection. Its products include Lucyd Lyte, Nautica, Eddie Bauer, Lucyd Armor line, and Reebok. The firm derive substantially all of its revenue from the sale of smart glasses and custom lenses.
Intelligent Bio Solutions Inc is a medical technology company focused on developing and delivering intelligent, rapid, non-invasive testing and screening solutions. Its current active product is the Intelligent Fingerprinting Platform, consisting of a proprietary portable platform that analyzes fingerprint sweat using a one-time cartridge and portable handheld reader. Its flagship product, the Intelligent Fingerprinting Drug Screening System, is a two-part system of non-invasive, fingerprint sweat-based diagnostic testing products designed to detect drugs of abuse, including opiates, cocaine, methamphetamines, benzodiazepines, cannabis, methadone, and buprenorphine. The Company operates in APAC, the UK, the Americas, and the rest of the world, with maximum revenue from the United Kingdom.